how to use a semaglutide pen Administration Using the Wegovy Injection Pen:

Serial InBody assessments reveal adaptation through: Falling BMR despite maintained or reduced weight Muscle loss with simultaneous fat regain after stopping therapy Slower weight loss plateau despite continued medication Declining phase angle indicates cellular health deterioration Tracking these trends is essential for understanding why weight regain is common after stopping GLP-1 therapy and why concurrent muscle preservation strategies are non-negotiable in any complete semaglutide management programme

Wegovy European Medicines Agency

And, more importantly, how worried should you be

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1) a hormone naturally released in the gut when food is consumed

Theyre serious medications for a serious disease, she says

Semaglutide mimics a hormone your gut produces after eating - it tells your brain you're full, slows how quickly your stomach empties, and improves how your body manages blood sugar